rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2008-3-3
|
pubmed:abstractText |
To evaluate the rate of prophylactic contralateral mastectomy in an international cohort of women with hereditary breast cancer and to evaluate the predictors of uptake of preventive surgery.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AinsworthPeterP,
pubmed-author:CummingsShellyS,
pubmed-author:DomchekSusanS,
pubmed-author:FoulkesWilliam DWD,
pubmed-author:FriedmanEitanE,
pubmed-author:GhadirianParvizP,
pubmed-author:GronwaldJacekJ,
pubmed-author:Hereditary Breast Cancer Clinical Study Group,
pubmed-author:IsaacsClaudineC,
pubmed-author:Kim-SingCharmaineC,
pubmed-author:LubinskiJanJ,
pubmed-author:LynchHenryH,
pubmed-author:MøllerPålP,
pubmed-author:ManoukianSiranoushS,
pubmed-author:MetcalfeKelly AKA,
pubmed-author:NarodSteven ASA,
pubmed-author:SunPingP,
pubmed-author:TungNadineN,
pubmed-author:WagnerTeresaT,
pubmed-author:WeitzelJeffreyJ
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1093-7
|
pubmed:meshHeading |
pubmed-meshheading:18195327-Adult,
pubmed-meshheading:18195327-Breast Neoplasms,
pubmed-meshheading:18195327-Cohort Studies,
pubmed-meshheading:18195327-Female,
pubmed-meshheading:18195327-Genes, BRCA1,
pubmed-meshheading:18195327-Genes, BRCA2,
pubmed-meshheading:18195327-Genetic Predisposition to Disease,
pubmed-meshheading:18195327-Humans,
pubmed-meshheading:18195327-Mastectomy,
pubmed-meshheading:18195327-Middle Aged,
pubmed-meshheading:18195327-Mutation,
pubmed-meshheading:18195327-Ovariectomy,
pubmed-meshheading:18195327-Prognosis,
pubmed-meshheading:18195327-Prospective Studies,
pubmed-meshheading:18195327-Questionnaires,
pubmed-meshheading:18195327-Risk Assessment
|
pubmed:year |
2008
|
pubmed:articleTitle |
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
|
pubmed:affiliation |
Lawrence Bloomberg Faculty of Nursing, University of Toronto, Canada.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|